Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

AstraZeneca’s Tagrisso approved by FDA to treat EGFR-mutated lung cancer

More than 200,000 people are diagnosed with lung cancer in the US every year

- PMLiVE

FDA grants rare paediatric disease designation to Enterprise’s cystic fibrosis candidate

The genetic disease is estimated to affect more than 100,000 people globally

- PMLiVE

UCB shares positive two-year results for Bimzelx in hidradenitis suppurativa

The inflammatory skin disease affects about 1% of the population in most studied countries

- PMLiVE

Quality in Care (QiC) Dermatology 2025

The Awards recognise initiatives that improve the quality of life for people living with skin conditions

- PMLiVE

Supporting Blood Cancer Patients: The Importance of Patient-Centric Pharma Campaigns

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, understanding, and support for those living with blood cancers.

Mednet

Advantages of Virtual Collaboration – Perks of Virtual Medical Education

From extended reach and enhanced interactivity to increased speed and flexibility, learn why virtual settings are becoming a staple in education and professional interaction. Embrace the future of collaboration today!

Impetus Digital

- PMLiVE

Sanofi’s Sarclisa granted FDA approval to treat newly diagnosed multiple myeloma

Approximately 32,000 people are diagnosed with the haematological malignancy in the US every year

- PMLiVE

LEO Pharma’s Anzupgo cream approved by EC to treat chronic hand eczema

About 70% of patients with severe cases of the skin condition report problems performing everyday activities

- PMLiVE

Eli Lilly/Almirall share positive long-term results for Ebglyss in atopic dermatitis

The inflammatory skin condition occurs in approximately 7.3% of adults in the US

- PMLiVE

Drug safety risk analysis – solving the puzzle of unstructured data

Patients are increasingly using non-traditional reporting channels to seek guidance on drug safety events

- PMLiVE

Championing people-powered communications in rare diseases: AMICULUM’s feature in The Guardian Rare Diseases Campaign 2024

By Ellie Thomas

Amiculum

- PMLiVE

Astellas’ Vyloy combination approved by EC as first-line gastric cancer treatment

Approximately 136,000 cases of the disease are diagnosed in Europe every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links